> Imprima

Molecular Profiling in Advanced Non–Small Cell Lung Cancer: Navigating the New Treatment

Ultima Vez Modificado: 6 de abril del 2015

Faculty

Corey J. Langer, MD, FACP

Tracey L. Evans, MD

Beth Eaby-Sandy, MSN, CRNP, OCN 

CME/CE Released: 02/24/2015; Valid for credit through 02/24/2016.

This activity was developed for a multidisciplinary audience that includes medical, surgical, and radiation oncologists, hematologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with NSCLC. 

The goal of this educational program is to provide an update on evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC based on the results of molecular and genetic testing. 

Upon completion of this activity, participants should be able to: 

  • Review evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC 
  • Integrate molecular and genetic testing results in the treatment of NSCLC 
  • Discuss interdisciplinary care of patients with advanced NSCLC

Continue to Activity

Blogs

Don't Assume You Understand
by Bob Riter
July 29, 2015